Skip to main content
Clinical Trials/CTRI/2024/08/072724
CTRI/2024/08/072724RecruitingPhase 2

A Single Arm Clinical Trial to Evaluate the Artava Janaka properties of Kashmarya Kshudrasaha Granules in the Management of Vataja Artava Dushti W.S.R to Oligohypomenorrhoea

Meghna Vaman Nayak1 site in 1 country70 target enrollmentStarted: August 30, 2024Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Sponsor
Enrollment
70
Locations
1
Primary Endpoint
Artava Janana Effect of kashmarya- kshudrasaha granules in vataja artava dushti W.S.R. to Oligo-hypomenorrhoea on the basis of Pictoral Blood Assessment Chart, artava srava swaroopa chart, artava srava kalaavdhi chart, duration between two artava darshana both before and after treatment.

Study Overview

Brief Summary

This is a Single Arm Clinical Trial to Evaluate the Artava Janaka properties of Kashmarya Kshudrasaha Granules in the Management of Vataja Artava Dushti W.S.R to Oligohypomenorrhoea.

70 patients selected according to inclusion criteria will be administered with kashmarya-kshudrasaha granules orally mixed with milk twice a day in a single dose of 1 karsha (10g) for 3 menstrual cycles.

The Primary outcome measures will be improvement in the amount of menstrual bleeding & reducing the inter-menstrual duration. This will be assessed by subjective parameters i.e. Artava srava swaroopa (Appearance of menstrual blood),Artavasrava Kalaavadhi (Duration of Menstrual Flow) & Duration of Artava darshan (Interval between two cycles) and subjective parameter i.e. by comparing the changes in Pictorial Blood Chart before and after treatment. The total duration of the study is 18 months.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
13.00 Year(s) to 19.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • ••All female patients in the Age group of 13-19 years who are willing to participate in the study who are having symptoms of vataja artava dushti.
  • ••With symptoms of oligo-hypomenorrhea i.e. inter-menstrual duration more than 35 days and menstrual bleeding flow less than 2 days.
  • ••Female patients irrespective of caste, education, income group and any occupation will be selected.
  • ••Hemoglobin 9 g % and above.
  • ••BMI – 18-27.

Exclusion Criteria

  • ••K/C/O of any major systemic diseases.
  • ••K/H/O of Mullerian Duct Anomalies.
  • ••Intermenstrual duration more than 60 days.

Outcomes

Primary Outcomes

Artava Janana Effect of kashmarya- kshudrasaha granules in vataja artava dushti W.S.R. to Oligo-hypomenorrhoea on the basis of Pictoral Blood Assessment Chart, artava srava swaroopa chart, artava srava kalaavdhi chart, duration between two artava darshana both before and after treatment.

Time Frame: 3 menstrual cycles

Secondary Outcomes

  • Improvement in Vataja artava dushti condition i.e. improving the amount of menstrual bleeding & reducing the inter-menstrual duration.(3 menstrual cycles)

Investigators

Sponsor
Meghna Vaman Nayak
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Meghna Vaman Nayak

Yashwant Ayurvedic College, Post Graduate Training and Research Centre

Study Sites (1)

Loading locations...

Similar Trials